Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.01)
# 536
Out of 4,959 analysts
79
Total ratings
41.25%
Success rate
16.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.45 | +175.86% | 2 | Aug 8, 2025 | |
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $105.56 | +51.57% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $28.05 | +178.07% | 1 | Jun 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $8.77 | +823.60% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $68.57 | +111.46% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $14.85 | +243.43% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $1.19 | +404.20% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $9.88 | +385.83% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $43.96 | +111.56% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $17.63 | +325.41% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $27.03 | +288.46% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $25.04 | +47.76% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $2.01 | +1,193.53% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.95 | +2,847.37% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $30.92 | +213.71% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $26.18 | +190.30% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.54 | +606.21% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.99 | +130.95% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.26 | +128.14% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.20 | +2,042.86% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $20.04 | +798.20% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.34 | +541.03% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $414.68 | -18.97% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.16 | +406.33% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $20.22 | +295.65% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $19.61 | +374.25% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $23.31 | +178.85% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $15.24 | +274.02% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.11 | +842.33% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $57.48 | -39.11% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $8.83 | +885.28% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $10.20 | +1,615.69% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $38.34 | +87.79% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.43 | +101.48% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.74 | +1,724.82% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.13 | +3,439.82% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.35 | +5,117.39% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.98 | +2,528.29% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $18.51 | +315.99% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $71.52 | +7.66% | 1 | Jul 31, 2020 |
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.45
Upside: +175.86%
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $105.56
Upside: +51.57%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $28.05
Upside: +178.07%
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $8.77
Upside: +823.60%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $68.57
Upside: +111.46%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $14.85
Upside: +243.43%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.19
Upside: +404.20%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $9.88
Upside: +385.83%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $43.96
Upside: +111.56%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $17.63
Upside: +325.41%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $27.03
Upside: +288.46%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $25.04
Upside: +47.76%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $2.01
Upside: +1,193.53%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.95
Upside: +2,847.37%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $30.92
Upside: +213.71%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $26.18
Upside: +190.30%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.54
Upside: +606.21%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.99
Upside: +130.95%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.26
Upside: +128.14%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.20
Upside: +2,042.86%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $20.04
Upside: +798.20%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.34
Upside: +541.03%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $414.68
Upside: -18.97%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.16
Upside: +406.33%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $20.22
Upside: +295.65%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $19.61
Upside: +374.25%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $23.31
Upside: +178.85%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $15.24
Upside: +274.02%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.11
Upside: +842.33%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $57.48
Upside: -39.11%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $8.83
Upside: +885.28%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $10.20
Upside: +1,615.69%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $38.34
Upside: +87.79%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.43
Upside: +101.48%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.74
Upside: +1,724.82%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.13
Upside: +3,439.82%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.35
Upside: +5,117.39%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.98
Upside: +2,528.29%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $18.51
Upside: +315.99%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $71.52
Upside: +7.66%